ReposiTrak (TRAK) director Allen discloses preferred stock sale and holdings

Rhea-AI Filing Summary

ReposiTrak director Robert W. Allen reported selling 8,280 shares of Series B Preferred Stock at $10.70 per share on 12/31/2025. After this transaction, he directly held 22,411 shares of Series B Preferred Stock. He also reported direct ownership of 199,147 shares of common stock, plus indirect holdings of 587,476 common shares through a trust and 2,775 common shares held by his spouse.

Insider Trade Summary

Net Seller: 8,280 shares

Net Sell 4 txns

Insider ALLEN ROBERT W

Role Director

Type	Security	Shares	Price	Value
Disposition	Series B Preferred Stock	8,280	$10.70	$89K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Series B Preferred Stock — 22,411 shares (Direct); Common Stock — 199,147 shares (Direct); Common Stock — 587,476 shares (Indirect, By Trust); Common Stock — 2,775 shares (Indirect, By Spouse)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/07/2026 - 04:30 PM Learn about SEC filing dates

FAQ

What insider transaction did ReposiTrak (TRAK) director Robert W. Allen report?

Robert W. Allen reported a disposition of 8,280 shares of ReposiTrak Series B Preferred Stock at $10.70 per share on 12/31/2025.

How many Series B Preferred shares does Robert W. Allen hold after this Form 4 filing for TRAK?

Following the reported transaction, Robert W. Allen directly owned 22,411 shares of ReposiTrak Series B Preferred Stock.

What are Robert W. Allen’s direct common stock holdings in ReposiTrak (TRAK)?

As of the reported date, Robert W. Allen directly held 199,147 shares of ReposiTrak common stock.

What indirect ReposiTrak common stock holdings are reported for Robert W. Allen?

The filing shows indirect ownership of 587,476 ReposiTrak common shares held by a trust and 2,775 common shares held by his spouse.

What is Robert W. Allen’s relationship to ReposiTrak (TRAK)?

Robert W. Allen is reported as a director of ReposiTrak, Inc. in this Form 4 filing.

Was the reported ReposiTrak (TRAK) insider transaction made under a Rule 10b5-1 plan?

The excerpt includes standard language about Rule 10b5-1 plans, but it does not indicate that the transaction was marked as being made under such a plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ALLEN ROBERT W

(Last) (First) (Middle)

5282 S COMMERCE DRIVE, SUITE D-292

(Street)

MURRAY UT 84107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ReposiTrak, Inc. [ TRAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series B Preferred Stock	12/31/2025		D		8,280	D	$10.7	22,411	D
Common Stock								199,147	D
Common Stock								587,476	I	By Trust
Common Stock								2,775	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Robert Allen	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.